跳到主要内容
Learn Motion
探索课程产品能力价格

下载 Learn Motion

用手机扫描二维码,下载 App。

App Store

扫码从 App Store 下载 Learn Motion打开商店页面

Google Play

扫码从 Google Play 下载 Learn Motion打开商店页面
登录
Learn Motion

Selective Killing: How Chemotherapy Harms Cancer Cells More Than Normal Cells

1The Selectivity Problem: Why Preferential Killing Is Possible but Imperfect2Proliferation as the Primary Vulnerability: Cell-Cycle Dependence3Antimetabolites and the S-Phase Trap4Microtubule Poisons and Mitotic Arrest5DNA-Damaging Agents: Alkylators, Crosslinkers, and Topoisomerase Poisons6The DNA-Damage Response and the Decision to Die7Why Selectivity Fails: Normal-Tissue Toxicity and the Limits of the Window8Resistance: How Tumors Escape and What It Reveals About Selectivity9Widening the Window: Clinical Strategies That Exploit Selectivity
The DNA-Damage Response and the Decision to Die

Reading the Break: ATM, ATR, and the p53 Decision Point

1 / 3
Start at the broken end. The MRN complex binds it and recruits ATM, which activates itself at the break. ATR responds to a different structure — single-stranded DNA coated by RPA, which appears when a fork stalls. Both kinases activate Chk proteins, and Chk phosphorylates p53 at serine 20. That modification blocks MDM2 from binding p53, so p53 is no longer degraded and accumulates. Once p53 is high, it turns on two sets of genes: p21, which arrests the cell at the G1/S boundary, and PUMA and NOXA, which push toward apoptosis. Notice that the diagram shows both outputs active at once — the outcome depends on which signal wins, not on a single switch.
0:00 / 0:00

A double-strand break is not a signal by itself. The cell must first detect it, then decide whether the damage is repairable. Two related kinases do the detection. ATM (ataxia-telangiectasia mutated) is recruited directly to the break by the MRN complex (MRE11–RAD50–NBS1), which binds the broken ends and holds them together. Once at the break, ATM autophosphorylates and becomes active. ATR (ataxia-telangiectasia and Rad3-related) responds to a different structure: single-stranded DNA coated by RPA, which appears when a fork stalls or when resection exposes a template strand. ATR is recruited by ATRIP and activated by TOPBP1.

Both kinases converge on the checkpoint kinases Chk2 (downstream of ATM) and Chk1 (downstream of ATR). The Chk kinases phosphorylate p53 at serine 20, which disrupts the MDM2–p53 interaction. MDM2 normally binds p53 and targets it for ubiquitin-mediated degradation; when that binding is blocked, p53 escapes degradation and accumulates. ATM also phosphorylates p53 directly at serine 15, adding a second stabilizing modification.

Accumulated p53 acts as a transcription factor. Among its targets are CDKN1A, which encodes p21, a cyclin-dependent kinase inhibitor that blocks the G1/S transition and holds the cell in G1 while repair proceeds. p53 also transcribes pro-apoptotic genes including PUMA and NOXA. The choice between arrest and death is therefore not a single switch but a balance: if repair succeeds, p53 levels fall and the cell re-enters the cycle; if damage persists, the apoptotic arm dominates. This is the decision point that determines whether a DNA-damaging drug kills the cell or merely pauses it.

参考资料

  1. [1]ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Responsepubmed.ncbi.nlm.nih.gov
  2. [2]The p53 pathway: positive and negative feedback loopspubmed.ncbi.nlm.nih.gov
上一页1 / 3下一页

Learn Motion

生成课程,认真学会。

运营方:Wuhan Daoyin Technology Co., Ltd.

联系我们: [email protected]
隐私政策用户服务协议

© 2026 Learn Motion